2K8-80631-18793 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-17
Registered in v-safe
2020-12-17
Dose 1 — Pfizer-BioNTech
2020-12-17
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-31
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-09
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-15
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-22
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-29
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-07
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-12
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-09
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-08-19
Dose 3 — Pfizer-BioNTech
2021-09-28
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-10-01
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-11-18
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-02-18
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-08-19
Survey response — 12 months, dose 3
MedDRA: Dizziness, Meniere's disease, Tinnitus, Vertigo — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Tinnitus, episodic vertiginous dizziness, diagnosed with Mnire's disease

MedDRA releases: 2024-11 · check-in free text available
2022-08-19
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-08-22
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-17	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech
3	2021-08-19	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-08-19	Unsuccessful

Free text

Release 12 — 12 months, dose 3

2022-08-19

Symptoms: Tinnitus, episodic vertiginous dizziness, diagnosed with Mnire's disease

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dizziness	·	·	✓
SD	Meniere's disease	·	·	✓
SD	Tinnitus	·	·	✓
SD	Vertigo	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release